07/09/2025
3:39 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Nektar Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/03/2025
1:07 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Nektar Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/01/2025
3:44 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2025
4:15 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2025
6:45 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
3:30 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2025
3:30 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2025
7:07 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
7:07 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
7:08 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
8:35 AM | BlackRock, Inc. (Filed by)
Nektar Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for NKTR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/15/2025
3:39 PM | Nektar Therapeutics (Filer)
| Form PRE 14A | |
04/01/2025
11:15 PM | Nektar Therapeutics (Filer)
| Form EFFECT | |
03/28/2025
3:22 PM | Nektar Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/14/2025
3:22 PM | Nektar Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2025
3:20 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2025
6:10 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
5:04 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:06 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:07 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
2:27 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
2:18 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
2:21 PM | Nektar Therapeutics (Subject)
ROBIN HOWARD W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
12:49 PM | Nektar Therapeutics (Subject)
SAMLYN CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
02/14/2025
11:08 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Nektar Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
7:43 AM | Deep Track Capital, LP (Filed by)
Nektar Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/17/2025
7:37 PM | GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/17/2025
7:39 PM | Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/17/2025
7:30 PM | Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/17/2025
7:32 PM | Brainard Diana (Reporting)
Nektar Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/17/2025
7:35 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
12/26/2024
6:04 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
8:35 AM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
2:21 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024
7:33 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
8:08 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
2:12 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
3:17 PM | Nektar Therapeutics (Subject)
ROBIN HOWARD W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
7:54 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:54 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:55 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
A grave, grave error. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
12/17/2024
2:29 PM | Nektar Therapeutics (Subject)
ROBIN HOWARD W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
8:24 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
7:37 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
7:36 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
7:36 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
2:17 PM | Nektar Therapeutics (Subject)
ROBIN HOWARD W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
2:28 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
11:17 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
8:18 AM | Deep Track Capital, LP (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
4:31 PM | BlackRock, Inc. (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G | |
11/07/2024
3:31 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
7:52 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
8:15 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
8:15 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
8:14 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:13 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
2:45 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
